Literature DB >> 28258232

Insights into drug resistance mechanisms in Clostridium difficile.

Phurt Harnvoravongchai1, Methinee Pipatthana1, Surang Chankhamhaengdecha2, Tavan Janvilisri3.   

Abstract

The incidence of Clostridium difficile infection has been elevated and becoming common in hospitals worldwide. Although antibiotics usually serve as the primary treatment for bacterial infection including C. difficile infection, limitations and failures have been evident due to drug resistance. Antibiotic resistance in C. difficile has been recognized as one of the most important factors to promote the infection and increase the level of severity and the recurrence rate. Several outbreaks in many countries have been linked to the emergence of hypervirulent drug-resistant strains. This pathogen harbours various mechanisms against the actions of antibiotics. The present study highlights three main drug-resistant strategies in C. difficile including drug inactivation, target modification and efflux pump. Other mechanisms that potentially contribute to drug-resistant traits in this organism are also discussed.
© 2017 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  Clostridium difficile; antibiotics; drug resistance; molecular mechanisms

Mesh:

Substances:

Year:  2017        PMID: 28258232     DOI: 10.1042/EBC20160062

Source DB:  PubMed          Journal:  Essays Biochem        ISSN: 0071-1365            Impact factor:   8.000


  11 in total

1.  Curcumin: A natural derivative with antibacterial activity against Clostridium difficile.

Authors:  Deepansh Mody; Ahmad I M Athamneh; Mohamed N Seleem
Journal:  J Glob Antimicrob Resist       Date:  2019-10-14       Impact factor: 4.035

Review 2.  Antimicrobial resistance in Clostridioides difficile.

Authors:  Keeley O'Grady; Daniel R Knight; Thomas V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-08-24       Impact factor: 3.267

3.  Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile.

Authors:  Matthew Phanchana; Tanaporn Phetruen; Phurt Harnvoravongchai; Ponlawoot Raksat; Puey Ounjai; Surang Chankhamhaengdecha; Tavan Janvilisri
Journal:  Sci Rep       Date:  2020-04-16       Impact factor: 4.379

4.  Prevalence and antimicrobial resistance pattern of Clostridium difficile among hospitalized diarrheal patients: A systematic review and meta-analysis.

Authors:  Tebelay Dilnessa; Alem Getaneh; Workagegnehu Hailu; Feleke Moges; Baye Gelaw
Journal:  PLoS One       Date:  2022-01-13       Impact factor: 3.240

5.  The repertoire of ABC proteins in Clostridioides difficile.

Authors:  Methinee Pipatthana; Phurt Harnvoravongchai; Pisut Pongchaikul; Somsak Likhitrattanapisal; Matthew Phanchana; Surang Chankhamhaengdecha; Tavan Janvilisri
Journal:  Comput Struct Biotechnol J       Date:  2021-05-08       Impact factor: 7.271

6.  Lauric Acid Is an Inhibitor of Clostridium difficile Growth in Vitro and Reduces Inflammation in a Mouse Infection Model.

Authors:  Hsiao-Ting Yang; Jenn-Wei Chen; Jagat Rathod; Yu-Zhen Jiang; Pei-Jane Tsai; Yuan-Pin Hung; Wen-Chien Ko; Daniel Paredes-Sabja; I-Hsiu Huang
Journal:  Front Microbiol       Date:  2018-01-17       Impact factor: 5.640

7.  CD2068 potentially mediates multidrug efflux in Clostridium difficile.

Authors:  Chawalit Ngernsombat; Suthasinee Sreesai; Phurt Harnvoravongchai; Surang Chankhamhaengdecha; Tavan Janvilisri
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

8.  Characterization of Bacteriophages Infecting Clinical Isolates of Clostridium difficile.

Authors:  Wichuda Phothichaisri; Puey Ounjai; Tanaporn Phetruen; Tavan Janvilisri; Pongsak Khunrae; Sombat Singhakaew; Piyada Wangroongsarb; Surang Chankhamhaengdecha
Journal:  Front Microbiol       Date:  2018-07-31       Impact factor: 5.640

9.  Antimicrobial Effect of Asiatic Acid Against Clostridium difficile Is Associated With Disruption of Membrane Permeability.

Authors:  Phurt Harnvoravongchai; Surang Chankhamhaengdecha; Puey Ounjai; Sombat Singhakaew; Kanpong Boonthaworn; Tavan Janvilisri
Journal:  Front Microbiol       Date:  2018-09-07       Impact factor: 5.640

10.  In Vitro Investigation of Auranofin as a Treatment for Clostridium difficile Infection.

Authors:  Christine Roder; Eugene Athan
Journal:  Drugs R D       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.